Trials / Active Not Recruiting
Active Not RecruitingNCT06533670
TME Alteration in HER2 Positive Breast Cancer
Tumor Microenvironment Alteration During Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer Patients
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate for changes in the tumor microenvironment before/during neoadjuvant chemotherapy and after treatment in patients diagnosed with HER2-positive advanced breast cancer and receiving neoadjuvant cancer therapy and surgery for curative purposes.
Conditions
Timeline
- Start date
- 2024-07-19
- Primary completion
- 2026-07-19
- Completion
- 2026-07-19
- First posted
- 2024-08-01
- Last updated
- 2026-01-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06533670. Inclusion in this directory is not an endorsement.